Literature DB >> 2247486

Growth control of normal and malignant breast epithelium.

M E Lippman1, R B Dickson.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2247486

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  7 in total

Review 1.  New generation aromatase inhibitors in breast cancer. Weighing out potential costs and benefits.

Authors:  G M Higa
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Targeting HER2 in breast cancer: overview of long-term experience.

Authors:  Evan Lantz; Ivan Cunningham; Gerald M Higa
Journal:  Int J Womens Health       Date:  2010-08-09

Review 3.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

Authors:  B I Dalal; P A Keown; A H Greenberg
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  Clinical breast cancer research core.

Authors:  S M Swain; S F Honig; E Egan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

6.  Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.

Authors:  N Matsumoto-Taniura; K Matsumoto; T Nakamura
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

7.  Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells.

Authors:  V M Macaulay; J E Nicholls; J Gledhill; M G Rowlands; M Dowsett; A Ashworth
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.